MiRA System
Acute Respiratory Failure (ARF)
Pre-clinicalActive
Key Facts
About HBOX Therapies
HBOX Therapies is a German medical device startup developing the MiRA system, a novel extracorporeal respiratory support device for acute respiratory failure. The technology integrates three proprietary innovations—an advanced artificial lung, an augmented gas management system, and a novel blood pump—to enable efficient gas exchange with reduced blood damage and device complexity. Founded in 2021 by a team with deep expertise in cardiovascular engineering from RWTH Aachen, the company is in the pre-clinical/development stage, targeting a significant unmet need in intensive care. HBOX aims to improve patient outcomes and reduce ICU burden by providing a safer alternative to invasive mechanical ventilation.
View full company profile